thank you @medsci.ox.ac.uk for working together to get advances in health & care to people most likely to benefit.
1) Is #informedconsent part of the protocol?
2) Might a #HumanImmuneMonitoringCenter mitigate risk of adverse events?
3) #Expandedaccess to parents & caregivers? #ItTakesaVillage

The Latest ALS News: Expanded access program for ALS drug MN-166 at 50% enrollment. ALSNewsToday.com

ALS Access Update: https://bit.ly/3MtWLSG

An expanded access program for the experimental therapy MN 166 has reached fifty percent enrollment.

#ALS #ALSNewsToday #Bionews #ALSResearch #ExpandedAccess #ClinicalTrials #ALSTreatment #RareDiseaseNews

Q3 Clinical trials round-up: July to September 2025 As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.

#drugdevelopment #Clinicaltrials #RandD #clinicalresearch #neurodegeneration #regenerativemedicine #clinicaltrialdevelopments #orphandrugdesignation #preclinicaldata #fasttrackdesignation #expandedaccess #FDApriorityreview #clinicalprogress #strategicfunding
zurl.co/jmZiW

#CellandGeneTherapy #CGT #Uniphar #personalisedmedicine #Celltherapy #CARTcelltherapy #Genetherapy #CGTlandscape #CGTpipeline #genetherapytrials #Expandedaccess #NamedPatientSupply #FreeofChargeaccess #FOCaccess #MAPs #EAPs #realworldevidencegeneration #marketreadiness
zurl.co/2pdyj

New NHS diabetes strategy could raise GLP-1 drug use New guidelines on NHS management of type 2 diabetes will introduce a more personalised approach that could see expanded access to drug treatments

#NHSdiabetesstrategy #GLP1 #NHS #type2diabetes #personalisedapproach #expandedaccess #GLP1agonisttherapies #NHScosts #Individualisedcare #NICEdraftguidance #NICE #SGLT2inhibitors #GLP1receptoragonists #NICEguidance #NHS10Yearplan #patientadvocacy #DiabetesUK
pharmaphorum.com/news/new-nhs...

Where you live shouldn’t limit your access to treatments and clinical trials.

That’s why we are proud to lead the FIRST virtual clinical study via Clene's #ExpandedAccess Program

Learn more: www.synapticure.com/blog/increas...

#ALSAwareness #ALSResearch #EndALS

🚀How early could an EAP be launched?

It's all about the risk benefit balance

When should a Global Expanded Access Program (EAP) be launched? The answer depends on compelling clinical data—sometimes as early as Phase 1 or Phase 2.

#ExpandedAccess #EarlyAccess #EAP

🚀 Pivotal Data release triggers requests for Early Access.

When pivotal clinical data is released—whether at ASCO or another major medical symposium—healthcare professionals worldwide ask the same critical question:

#ExpandedAccess #PivotalData #EarlyAccess #ASCO #ClinicalTrials

🚀 Companies Starting EAPs After First Approval

Some pharmaceutical companies choose to initiate an Expanded Access Program (EAP) only after securing their first regulatory approval.

#ExpandedAccess #EarlyAccess #EAP #DrugApproval

🚀 Risk minimisation: Launchng an EAP post first country regulatory approval.

Can EAPs be launched after the first regulatory approval has been granted? Some companies only commence EAPs at this time.

#ExpandedAccess #EarlyAccess #EAP #DrugApproval

🚀 4 Core Policy Decisions for Setting Up an Expanded Access Program (EAP)

When establishing an Expanded Access Program (EAP), making the right policy decisions early on is crucial. Here are the four key considerations:

#ExpandedAccess #EarlyAccess #EAP #CompassionateUse